Risk of hypertension amongst Swedish male snuff users: a prospective study
The scientific evidence on whether long-term use of snuff is associated with high blood pressure is limited, inconsistent and based only on cross-sectional data. We aimed at studying the risk of hypertension in relation to long-term use of snuff based on longitudinal data. Repeated health check-ups were offered to all employees in the Swedish construction industry between 1978 and 1993. Blood pressure was measured at the health check-up and information on tobacco use and other risk factors was collected through questionnaires. In total, 120 930 never smoking men with information on blood pressure and snuff use at baseline were included. The association of high blood pressure and snuff use at baseline was estimated by logistic regression. Further, 42 055 men were identified as normotensive at baseline and had at least one subsequent health check-up. Through repeated blood pressure measurements and linkage to the Swedish National Inpatient Register, information on hypertension was obtained. Relative risk estimates were derived from Cox proportional hazards regression model. Almost 30% of all men had used snuff. The adjusted odds ratio of high blood pressure amongst snuff users at baseline was 1.23 (95% CI 1.15-1.33) compared to never snuff users. The relative risk of high blood pressure during follow-up was 1.39 (95% CI 1.08-1.79) amongst snuff users and 1.36 (95% CI 1.07-1.72) for hypertension as recorded in the Inpatient Register. Use of Swedish moist snuff appears to be associated with a moderately increased risk of hypertension.
155
- 10.1136/bmj.305.6864.1252
- Nov 21, 1992
- BMJ
120
- 10.1146/annurev.med.37.1.21
- Jan 1, 1986
- Annual Review of Medicine
143
- 10.1016/s0735-1097(99)00409-x
- Nov 1, 1999
- Journal of the American College of Cardiology
132
- 10.1007/bf02247429
- Sep 1, 1992
- Psychopharmacology
127
- 10.1016/s0895-7061(98)00137-x
- Oct 1, 1998
- American Journal of Hypertension
90
- 10.2105/ajph.82.3.417
- Mar 1, 1992
- American Journal of Public Health
75
- 10.1111/j.1360-0443.2006.01550.x
- Sep 1, 2006
- Addiction (Abingdon, England)
113
- 10.1111/j.1365-2796.2007.01816.x
- Jun 26, 2007
- Journal of Internal Medicine
81
- 10.1097/00007611-199507000-00004
- Jul 1, 1995
- Southern Medical Journal
67
- 10.1136/tc.2006.018069
- Feb 1, 2007
- Tobacco Control
- Research Article
36
- 10.1177/1010539512446957
- May 31, 2012
- Asia Pacific Journal of Public Health
Despite scientific evidence about the harmful effects of smokeless tobacco (SLT), it is widely used in Bangladesh. This study explored perceptions about health effects of SLT use. Semistructured interviews were conducted with 1812 nonsmoking adults. About 40% of the participants were current SLT users or had used SLT in the past. Family members' influence was the main factor for initiation. The participants believed that people continued using SLT because of addiction (52%) and as a part of their lifestyle (23%). The majority of participants (77%) did not mention any benefit, but SLT users considered it to be a remedy for toothache (P < .05). Almost all participants mentioned that SLT was harmful and causes heart disease, cancer, and tuberculosis. Doctors' advice was the common motivating factor to quit. Health promotion interventions should highlight the adverse effects of SLT use, which outweigh the perceived benefits, and should consider addressing the role of family in SLT initiation and use.
- Research Article
12
- 10.1111/dar.13243
- Jan 20, 2021
- Drug and alcohol review
Smokeless tobacco (ST) is the predominant form of tobacco used in Bangladesh and is associated with adverse health outcomes. Bangladesh ratified the World Health Organization's Framework Convention on Tobacco Control (FCTC) in 2004. There are concerns that FCTC legislation and implementation of ST control policy is insufficient in Bangladesh. The aim of this study was to investigate the achievements and challenges of ST policy in Bangladesh and its alignment with the FCTC. We conducted semi-structured key informant interviews with 20 stakeholders from government and non-government offices and international funding agencies, including tobacco control advocates, policy makers and non-governmental organisation workers. We used NVivo software to create key themes and the framework method for thematic analysis. Our findings revealed a lack of national policy in terms of disclosure of harmful contents, illicit trade and standardised packaging of ST. Legislation remains ineffective in relation to graphical health warnings and tax measures. Challenges to ST control identified included inadequate law enforcement; paucity of research, surveillance, and evidence generation; and supply chain control. We identified lack of congruence of ST policies with FCTC due to slow progress in implementation of FCTC measures, lack of a country-specific policy and industry interference. To comply with FCTC, participants recommended strong leadership and political commitment, co-ordination between public and private sectors and proper use of tobacco control resources. Bangladesh has adopted several important FCTC measures, but further strengthening of ST policy is needed to enable full implementation of FCTC.
- Research Article
- 10.1093/ntr/ntae267
- Nov 15, 2024
- Nicotine & Tobacco Research
IntroductionSnus is suggested as a risk factor for cardiometabolic disease, but little is known about health effects in young populations, particularly in women. We aimed to investigate associations between snus and cardiometabolic health markers among young men and women.Aims and MethodsThis study was conducted within the BAMSE (Swedish acronym for Children, Allergy, Environment, Stockholm, Epidemiology) birth cohort and included participants followed up around 24 years (n = 2256) and 26 years (n = 1011). Snus use was assessed at 24 years by questionnaires. Cardiometabolic health markers were recorded at clinical examinations at 24 and 26 years. Associations between snus use and cardiometabolic markers were assessed by multivariable linear regression.ResultsSnus was used by 6.4% (n = 81) among women and 21.9% (n = 219) among men. Compared to no tobacco use, daily exclusive snus use among women at 24 years was associated with higher body mass index (BMI) (adjusted β: 1.93 kg/m2, 95% confidence interval [CI] = 0.54, 3.33) and waist circumference (WC) (aβ: 3.80 cm, 95% CI = 0.41, 7.18) at 24 years, and with higher BMI (aβ: 2.73 kg/m2, 95% CI = 0.53 to 4.93) at 26 years. Among men, using ≥4 cans/week was associated with increased BMI (aβ: 2.48 kg/m2, 95% CI = 0.73, 4.24) and a tendency toward increased body fat (aβ: 2.31%, 95% CI = −0.53, 5.14) at 26 years. Snus use was not associated with glycemic status or blood pressure.ConclusionsOur results suggest that snus is associated with increased BMI, and possibly other measures of adiposity, among young women and heavy-using young men. Given the cross-sectional study design, the results should be interpreted with caution.ImplicationsWe found cross-sectional associations between snus use and measures of increased adiposity in a cohort of Swedish young adults, including BMI and WC among women and BMI among heavy snus-using men. We did not find associations between snus use and body fat %, glycemic status, or blood pressure. This is one of few studies to investigate the health effect of snus among both women and men as well as cardiometabolic health markers in young adults. Given the recent trends of increased snus use among young adults, our findings highlight the need for further research on snus on cardiometabolic health.
- Research Article
68
- 10.1093/aje/kwq191
- Aug 5, 2010
- American Journal of Epidemiology
Use of smokeless tobacco in the United States has been relatively constant in recent years, as tobacco companies continue aggressive marketing campaigns. The health effects of smokeless tobacco use need further documentation. Thus, the authors examined whether current use of smokeless tobacco was associated with increased incidence of cardiovascular disease (CVD) in 14,498 men and women aged 45-64 years at baseline (1987-1989) in the Atherosclerosis Risk in Communities (ARIC) Study. There were 2,572 incident CVD events (myocardial infarction, coronary revascularization, coronary death, or stroke) during a median of 16.7 years of follow-up (maximum = 19.1 years). Current use of smokeless tobacco at baseline was associated with 1.27-fold greater CVD incidence (95% confidence interval: 1.06, 1.52) than was nonuse, independently of demographic, socioeconomic, and lifestyle and other tobacco-related variables. Past use of smokeless tobacco was not associated with CVD incidence. In conclusion, current use of smokeless tobacco was associated with increased risk of CVD incidence in ARIC cigarette nonsmokers. Current users of smokeless tobacco should be informed of its harm and advised to quit the practice. Current cigarette smokers should also be given sufficient information on safe, therapeutic methods of quitting which do not include switching to smokeless tobacco.
- Research Article
50
- 10.1016/j.ihj.2013.06.005
- Jul 1, 2013
- Indian Heart Journal
Smokeless tobacco and cardiovascular disease in low and middle income countries
- Research Article
- 10.11591/ijphs.v5i1.4765
- Mar 1, 2016
- International Journal of Public Health Science (IJPHS)
This study sought to examine assumption between having ever used non-cigarette tobacco or smokeless tobacco, and a diagnosis of hypertension among a sample of 13, 086 United States adults participating in the National Health Interview Series from 2012-2014. A pseudo-panel analysis of data extracted from the Integrated Health Interview Series Survey was conducted. The generalized linear mixed model was used to quantify the effect of a history of non-cigarette tobacco, smokeless tobacco, and socio-demographic predictor variables on the response variable, a diagnosis of hypertension. The transformed data, based on the pseudo-panel technique, resulted in fifty-seven (57) birth cohorts and followed in 2012, 2013, and 2014. The mean age was 51.6 years (±12.4). The findings of this study revealed that the odds of hypertension diagnosis for non-cigarette tobacco users was 0.8846 times lower (95% CI: 0.7907, 0.9896) than non-users after adjusting for possible confounders such as age, language, education, income and years of smoking. Our study suggested that the association between the use of non-cigarette tobacco and the diagnosis of hypertension among the sample population is consistent enough to assume a less plausible association between the two variables.
- Research Article
- 10.1111/j.1365-2796.2008.02038.x
- Mar 10, 2009
- Journal of Internal Medicine
Errors and omissions in the study of snuff use and hypertension
- Research Article
1
- 10.3923/aje.2012.75.86
- Jun 15, 2012
- Asian Journal of Epidemiology
The study aimed to determine whether hospital controls could be used in case-control studies with minimal bias, where resource constraints limit recruitment of community controls. Hospital controls and community controls were compared for socio-demographic and risk factor variables in a study of Smokeless Tobacco (SLT) use and Coronary Heart Disease (CHD) in Bangladesh in 2010. Incident cases of CHD and hospital controls were selected from cardiac hospitals. Community controls were selected from neighbourhoods of CHD cases. We enrolled 302 cases, 302 hospital controls, and 1208 community controls. Distribution of age, gender, marital status, occupation, and socio-economic status was similar between hospital controls and community controls. Compared to community controls, hospital controls were more educated, had higher rates of hypertension and reported more family history of heart diseases. But they reported relatively less physical activity. Current use of SLT was higher amongst community controls compared to hospital controls, but was not significant (adjusted OR 0.81, 95% CI 0.58-1.12). Current use of SLT was not associated with an increased risk of CHD when community controls were used (adjusted OR 0.87, 95% CI 0.63 to 1.19, p>0.05), nor when hospital controls were used (adjusted OR 1.00, 95% CI 0.63 to 1.60, p>0.05). There were significant differences between two control groups but only on confounding variables which could be measured and adjusted for during multivariate analyses. For comparable future studies in resource-scarce settings, it is possible to enrol hospital controls with careful planning which are similar to potential community controls, whilst minimising selection bias.
- Research Article
24
- 10.1186/s12916-021-01979-6
- May 7, 2021
- BMC Medicine
BackgroundCigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whether smokeless tobacco such as snuff is associated with the risk of CVD is still unclear. We investigated the association of the use of Swedish oral moist snuff (snus) with a broad range of CVDs and CVD mortality.MethodsWe used data from a population-based cohort of 41,162 Swedish adults with a mean baseline age of 70 (56–94) years who completed questionnaires regarding snus use and other lifestyle habits and health characteristics. Participants were followed up for incident cardiovascular outcomes and death over 8 years through linkage to the Swedish National Patient and Death Registers. Hazard ratios (HR) were estimated by Cox proportional hazards regression. We conducted analyses among all subjects as well as among never smokers to reduce residual confounding from smoking.ResultsAfter adjustment for smoking and other confounders, snus use was not associated with myocardial infarction, heart failure, atrial fibrillation, aortic valve stenosis, abdominal aortic aneurysm, stroke, or CVD mortality. However, in never smokers, snus use was associated with a statistically significant increased risk of total and ischemic stroke (HRs [95% confidence intervals] = 1.52 [1.01–2.30] and 1.63 [1.05–2.54], respectively) and non-significantly positively associated with some other CVDs.ConclusionsIn this middle-aged and elderly Swedish population, current Swedish snus use was not associated with the risk of major heart and valvular diseases, abdominal aortic aneurysm, or CVD mortality in the entire study population, but was linked to an increased risk of stroke in never smokers.
- Research Article
70
- 10.1177/2047487316654026
- Jul 10, 2016
- European journal of preventive cardiology
Objective The purpose of this study was to assess the risk of ischaemic heart disease (IHD) and stroke (non-fatal and fatal) among adult ever-users of smokeless tobacco (ST). Design The study design involved a systematic review and meta-analysis of observational studies. Methods Data sources for the review included key electronic databases and reference lists. Studies were included based on design (cohort or case-control), exposure (exclusive use of ST or adjusted for smoking), and outcome (non-fatal and fatal IHD and stroke). Data extraction included reported measures of association (risk ratios (RRs) or odds ratios (ORs)) between ever-use of ST (current or past) and cardiovascular disease (CVD) outcomes among non-smokers, and other study characteristics. The Newcastle-Ottawa scale was used to assess study quality. Summary measures were estimated using random effects models. Results Twenty studies were included in the meta-analyses. Overall, significantly increased risk of IHD deaths (1.15, 95% confidence interval (CI: 1.01-1.30) and stroke deaths (1.39, 95% CI: 1.29-1.49) was found among ever-users of ST. We did not find an overall significant increased risk for IHD (1.14, 95% CI: 0.92-1.42) or stroke (1.01, 95% CI: 0.90-1.13). But geographical variations were marked for IHD, with significant positive association in Asian studies (1.40, 95% CI: 1.01-1.95), and the INTERHEART study, where ST data was mainly reported from Asia (2.23, 95% CI: 1.41-3.53). European studies did not show an increased risk for non-fatal CVD. Conclusion An association was found between ever use of ST and risk of fatal IHD and stroke, consistent with previous reviews. ST consumption also appears to significantly increase risk of non-fatal IHD among users in Asia, but not in Europe.
- Research Article
2
- 10.19813/j.cnki.weishengyanjiu.2021.02.008
- Mar 1, 2021
- Wei sheng yan jiu = Journal of hygiene research
To explore the association between different types of obesity and blood pressure in adolescents aged 12-17 years in eastern China. Using multi-stage stratified random sampling, a total of 8279 adolescents aged between 12 and 17 years in eastern China were selected as the research objects from the "Nutrition and Health Surveillance for Chinese Children and Nursing Mothers" project from 2016 to 2017. According to BMI and WHtR, the subjects were divided into four types: non-obesity, general obesity, simple abdominal obesity and combined obesity. The normal high blood pressure and high blood pressure of people with different types of obesity were determined according to Blood Pressure Standards for Children at 3-17 Years Old Per Year and Height in China. The relationship between different types of obesity and the prevalence of high blood pressure was analyzed by χ~2 test, analysis of variance, multi-level linear model and multi-level Logistic regression model. The prevalence of high normal blood pressure was 13. 66%(1069), and the prevalence of high blood pressure was 18. 79%(1782) in adolescents aged 12 to 17 years in eastern China. In the non-obese group, the prevalence of high normal blood pressure was 12. 85%(732), and the prevalence of high blood pressure was 13. 79%(999). In the general obesity group, the prevalence of high normal blood pressure was 20. 45%(99), and the prevalence of high blood pressure was 23. 62%(160). In the central obesity group, the prevalence of high normal blood pressure was 6. 95%(32), and the prevalence of high blood pressure was 14. 64%(87). The prevalence of high normal blood pressure was 16. 68%(206), and the prevalence of high blood pressure was 42. 42%(536) in the complex obesity group. The prevalence of high blood pressure(χ~2=8. 05, P<0. 01) the difference was statistically significant. Results of the multi-level model showed that the risk of high blood pressure in central obesity group was significantly higher in girls than in non-obese group(OR=1. 50, 95%CI 1. 12-2. 02). The risk of high normal blood pressure(OR=2. 05, 95%CI 1. 62-2. 58; OR=1. 83, 95%CI 1. 38-2. 42) and high blood pressure(OR=2. 06, 95%CI 1. 59-2. 67; OR=1. 57, 95%CI 1. 15-2. 14) in obese boys and girls were significantly higher than those in non-obese group. The risk of high normal blood pressure(OR=3. 80, 95%CI 3. 19-4. 51; OR=2. 79, 95%CI 2. 30-3. 37), high blood pressure(OR=4. 07, 95%CI 3. 39-4. 88; OR=2. 84, 95%CI 2. 32-3. 46) in both boys and girls with compound obesity was significantly higher than that in the non-obese group. Different types of obesity have varying degrees of correction with different blood pressure levels in adolescents aged 12-17 years, combined obesity has the highest risk of elevated blood pressure.
- Research Article
- 10.1161/hypertensionaha.120.15142
- Aug 1, 2020
- Hypertension (Dallas, Tex. : 1979)
Hypertension Editors' Picks: Air Pollution.
- Front Matter
- 10.1161/hypertensionaha.119.13143
- Jun 1, 2019
- Hypertension (Dallas, Tex. : 1979)
Hypertension Editors' Picks.
- Research Article
38
- 10.1111/j.1524-6175.2004.03609.x
- Nov 1, 2004
- Journal of clinical hypertension (Greenwich, Conn.)
Hypertension curriculum review: epidemiology and the prevention of hypertension.
- Front Matter
1
- 10.1016/j.jpeds.2010.04.022
- Jun 7, 2010
- The Journal of Pediatrics
Undetected Hypertension and Prehypertension in Children with Diabetes Need Attention
- Research Article
- 10.1161/circulationaha.113.004244
- Jul 9, 2013
- Circulation
<i>Circulation</i> Editors’ Picks
- Research Article
405
- 10.1161/01.hyp.35.5.1021
- May 1, 2000
- Hypertension
This clinical advisory statement from the Coordinating Committee of the National High Blood Pressure Education Program is intended to advance and clarify the recommendations of the Sixth Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI, 1997).1 The advisory addresses several interrelated issues about blood pressure (BP) that affect people approaching the later decades of life. On the basis of the wealth of currently available evidence, the committee now recommends a major paradigm shift in urging that systolic BP become the major criterion for diagnosis, staging, and therapeutic management of hypertension, particularly in middle-aged and older Americans. Several lines of strong evidence support the initiative to emphasize systolic BP. Pathophysiologically, there are strong associations among aging, increased stiffness of large arteries, increased systolic BP, increased pulse pressure, and the prevalence of cardiac and vascular disease. Epidemiologically, isolated systolic hypertension is the most common form of hypertension and is present in approximately two thirds of hypertensive individuals >60 years of age. Diagnostically, classification and staging of hypertension are more precise when systolic rather than diastolic BP is used as the principal criterion. Risk stratification for major complications of hypertension (stroke, myocardial infarction, heart failure, and kidney failure) is actually confounded by the use of diastolic BP; in older people with systolic hypertension, diastolic BP is inversely related to cardiovascular risk. Clinical benefits of treatment of isolated systolic hypertension include reductions in stroke, myocardial infarction, heart failure, kidney failure, and overall cardiovascular disease morbidity and mortality. Currently, only 1 in 4 Americans with hypertension falls below JNC VI–recommended values of 140/90 mm Hg in uncomplicated hypertension or 130/85 mm Hg in individuals with kidney disease or diabetes. Hypertension control rates are poorest in older people, primarily as a result of inadequate …
- Research Article
- 10.21048/ijnd/v51/i4/2014/54211
- Oct 2, 2014
- The Indian journal of nutrition and dietetics
The objective of the study was to examine the risks for high blood pressure associated with under nutrition and over nutrition among adolescents, as both forms of malnutrition coexist in India owing to nutritional transition. Adolescents (9-16 yrs) from schools catering to Lower Socio Economic class (LSE; 943 boys, 1000 girls) and High Socio Economic class (HSE; 867 boys, 1042 girls) were measured for weight, height, sitting height, body fat, skin folds and blood pressure. Results revealed that high prevalence of overweight in adolescents from HSE class compared to that in LSE (24.1% vs 2.2% in boys and 20.8% vs 3.9% in girls; p<0.01 for both) indicated risk for High Systolic Blood Pressure (HSBP) while high prevalence of stunting in LSE class (20.8% in boys and 11.8% in girls) indicated risk for High Diastolic Blood Pressure (HDBP). Leg height to height ratio showed significant inverse association with blood pressure levels. In LSE class, prevalence of HDBP was significantly higher than prevalence of HSBP in each quartile of BMI, body fat and skin folds. Increase in systolic blood pressure per unit increase of BMI, was higher in adolescents from LSE class (1.99 mmHg in boys and 1.03 mmHg in girls) compared to those in HSE class (0.91 mmHg in boys and 0.52 mmHg in girls) and this was also true for diastolic blood pressure. Implications of increase in BMI are serious for undernourished children than better nourished children. The observation therefore, underscores the need for planning strategies for preventing adiposity in adolescents from urban as well as rural and poor sections of Indian population.
- Research Article
2
- 10.3760/cma.j.issn.0253-3758.2015.04.007
- Apr 1, 2015
- Chinese journal of cardiovascular diseases
To observe the association between the leukocyte count and blood pressure value and hypertension risk in a Chinese community-based population. A total of 4 188 participants who took part in the baseline examination in 1992 and the follow-up survey in 2007 from the Chinese Multi-Provincial Cohort Study were included in this study. The relationship of leukocyte and blood pressure value and hypertension risk were evaluated by cross-sectional analyses.The prospective association between baseline leukocyte count and blood pressure changes and risk of hypertension were analyzed in 2 954 normotensive individuals at baseline examination.The associations between leukocyte count and blood pressure was evaluated with Spearman's rank correlation analyses and linear regression models,and the associations between leukocyte count and risk of hypertension was evaluated with logistic regression models. (1) The cross-sectional study results showed that the correlation coefficient of leukocyte count and systolic blood pressure and diastolic blood pressure was 0.208 and 0.154 (both P < 0.001), respectively.Multiple linear regression analyses showed that every 1×10(9)/L increment in leukocyte count was associated with 1.41 mmHg (1 mmHg = 0.133 kPa) systolic blood pressure increase (95% CI: 1.20-1.63 mmHg, P < 0.001) and 0.63 mmHg diastolic blood pressure increase (95% CI: 0.51-0.76 mmHg, P < 0.001). Multivariable logistic regression analyses showed that every 1×10(9)/L increment in leukocyte count was associated with a 15% increased risk of hypertension (OR: 1.15, 95% CI: 1.12-1.19, P < 0.001). (2) During 15 years of follow-up, 47.2% (1 394/2 954) normotensive individuals progressed to hypertension. Spearman's rank correlation analyses showed that, the correlation coefficient of leukocyte count and systolic blood pressure change and diastolic blood pressure change was 0.062 (P = 0.003) and 0.102 (P < 0.001), respectively.Multiple linear regression analyses showed that every 1×10(9)/L increment in baseline leukocyte count was associated with 1.03 mmHg systolic blood pressure increase (95% CI: 0.74-1.32 mmHg, P < 0.001) and 0.64 mmHg diastolic blood pressure increase (95% CI: 0.48-0.80 mmHg, P < 0.001). Multivariable logistic regression analyses showed that every 1×10(9)/L increment in leukocyte count was associated with a 9% increased risk of incident hypertension (OR: 1.09, 95% CI: 1.06-1.13, P < 0.001). Elevated leukocyte count is associated with increased blood pressure value and hypertension among Chinese community-based population, suggesting that inflammation may participate in the pathogenesis of hypertension.
- Research Article
5
- 10.1016/j.rec.2014.09.002
- Dec 5, 2014
- Revista Española de Cardiología (English Edition)
Association Between Anthropometry and High Blood Pressure in a Representative Sample of Preschoolers in Madrid
- Research Article
1
- 10.1161/hypertensionaha.114.03061
- May 1, 2014
- Hypertension
<i>Hypertension</i> Editors’ Picks
- Research Article
283
- 10.1161/hypertensionaha.114.03449
- May 5, 2014
- Hypertension
Hypertension is highly prevalent in the United States and worldwide. In the United States, 1 in 3 adults (≈73 million people) have hypertension. The financial and human costs of hypertension are substantial. The estimated costs attributable to hypertension in the United States alone in 2010 were $70 billion direct costs for medical treatments and $24 billion indirect costs because of lost productivity.1 Awareness and treatment of hypertension have improved considerably during the past several decades: >80% of all people with hypertension are aware of the condition and 75% are using antihypertensive medications.2,3 However, despite enormous effort and treatment-related expenditures, only 53% of those with documented hypertension have their blood pressure controlled.3 Older age (Figure 1), left ventricular hypertrophy, and obesity are important risk factors for uncontrolled or drug-resistant hypertension.4 Importantly, the foregoing are also risk factors for increased aortic stiffness.5 Figure 1. Hypertension prevalence and control rates as a function of age in the National Health and Nutrition Examination Survey 2003 to 2004. Data derived from Wong et al.44 During the past 2 decades, measures of aortic stiffness have emerged as important risk factors for progression of blood pressure and incident cardiovascular disease. Carotid femoral pulse wave velocity (CFPWV), a measure of aortic wall stiffness, increases markedly with age, particularly after midlife. For example, Framingham Heart Study investigators have shown that the prevalence of CFPWV ≥12 m/s increases from a few percentage before 50 years of age to ≥60% after 70 years of age (Figure 2A). Importantly, elevated CFPWV is associated with high risk for incident hypertension (Figure 2B) and cardiovascular disease (Figure 2C). Figure 2C should be interpreted within the context that a normal value (<95th percentile) for CFPWV in a healthy Framingham Heart Study reference sample <50 years of age was 8.1 …
- Research Article
13
- 10.1016/j.recesp.2014.05.025
- Dec 5, 2014
- Revista Española de Cardiología
Asociación entre antropometría y presión arterial alta en una muestra representativa de preescolares de Madrid
- Research Article
9
- 10.1177/1403494809105546
- May 18, 2009
- Scandinavian Journal of Public Health
To describe the consumption of snuff in a rural male population and to explore associations between snuff use and obesity. Tobacco use was explored in 834 men aged 30-75 years old who participated in a cross-sectional population survey in the municipality of Vara (participation rate was 81%). Self-reported questionnaires assessed the habits of smoking and snuff use. Anthropometric measures were obtained during a health examination. Of these men 21% (n = 179) were snuff users, 13% (n = 109) current smokers, and 65% (n = 546) were non-users. Of all snuff users 65% (n = 116) were former smokers, and 35% (n = 63) were exclusive snuff users (current users who never smoked). Among non-users 65% (n = 357) were never users and 35% (n = 189) had quit smoking without nicotine substitution. These men were characterized by abdominal obesity; OR 1.84 (1.08-3.12) (p = 0.002) (WHR 41.0) and OR 1.71 (1.08-2.72) (p = 0.022) (waist circumference 4102 cm). One can/week use of snuff among ex-smokers was associated with a 1.21 cm wider (0.05-2.36) (p = 0.041) waist circumference and 0.01 (0.00-0.02) units higher (p = 0.021) WHR. There were statistically significant associations between former smoking without current nicotine substitute and both general and abdominal obesity. No similar association with abdominal obesity was seen among exclusive snuff users. Abdominal obesity in current snuff users is limited to former smokers. The remaining effect of previous smoking has to be considered in future studies on obesity and related disorders in snuff users. Counselling among people who substitute snuff for smoking should include measures to prevent weight gain.
- Research Article
97
- 10.1016/j.jpeds.2007.07.014
- Oct 23, 2007
- The Journal of pediatrics
Ambulatory Blood Pressure and Increased Left Ventricular Mass in Children at Risk for Hypertension
- New
- Research Article
- 10.1111/joim.70040
- Nov 7, 2025
- Journal of internal medicine
- New
- Research Article
- 10.1111/joim.70036
- Nov 6, 2025
- Journal of internal medicine
- New
- Research Article
- 10.1111/joim.70037
- Nov 6, 2025
- Journal of internal medicine
- New
- Research Article
- 10.1111/joim.70039
- Nov 5, 2025
- Journal of internal medicine
- New
- Discussion
- 10.1111/joim.70013
- Nov 1, 2025
- Journal of internal medicine
- New
- Research Article
- 10.1111/joim.70038
- Oct 30, 2025
- Journal of internal medicine
- Research Article
- 10.1111/joim.70033
- Oct 23, 2025
- Journal of internal medicine
- Research Article
- 10.1111/joim.70035
- Oct 23, 2025
- Journal of internal medicine
- Research Article
- 10.1111/joim.70034
- Oct 23, 2025
- Journal of internal medicine
- Research Article
- 10.1111/joim.70032
- Oct 22, 2025
- Journal of internal medicine
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.